Karen Krasney - 13 Dec 2024 Form 4 Insider Report for CAPRICOR THERAPEUTICS, INC. (CAPR)

Signature
/s/ Linda Marban, Attorney-in-Fact
Issuer symbol
CAPR
Transactions as of
13 Dec 2024
Net transactions value
+$11,120
Form type
4
Filing time
16 Dec 2024, 09:25:06 UTC
Previous filing
04 Jan 2024
Next filing
06 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CAPR Common Stock Options Exercise $11,120 +8,000 +40% $1.39 28,047 13 Dec 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CAPR Stock Option (Right to Buy) Options Exercise $0 -3,000 -100% $0.000000 0 13 Dec 2024 Common Stock 3,000 $1.39 Direct F1, F2
transaction CAPR Stock Option (Right to Buy) Options Exercise $0 -5,000 -100% $0.000000 0 13 Dec 2024 Common Stock 5,000 $1.39 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on March 3, 2015 and was previously covering 30,000 shares at an exercise price of $5.78 per share, but was adjusted to reflect a 1-for-10 reverse split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020.
F2 Shares vested 1/48th on the first day of each month commencing April 1, 2015.
F3 This option was granted on June 2, 2016 and was previously covering 50,000 shares at an exercise price of $3.12 per share, but was adjusted to reflect a 1-for-10 reverse split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020.
F4 Shares vested 1/48th on the first day of each month commencing July 1, 2016.